Observational studyDiabetologia2026

Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.

Thijs T Jansz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.